AI for Science · Fri 6 Nov

AI for Science refers to the application of machine learning methods to accelerate scientific discovery and research workflows across academic and industrial laboratories. Truncated covers research papers, computational biology tools, materials discovery models, and laboratory automation updates.

Friday 6 November

Anthropic is making biotech boasts, but scientists are wary of hype around ‘curing cancer’

An image collage containing 3 images, Image 1 shows Dario Amodei, CEO and co-founder of Anthropic, at the World Economic Forum annual meeting, Image 2 shows Andreas Bender speaking at the Oncode Accelerator Summit, Image 3 shows Biochemist Sarah Martin works in a laboratory at Servier Pharmaceuticals, holding a pipette over a test tube

AI-generated summary Anthropic has been promoting its biotechnology initiatives by opening a Bay Area biology lab, purchasing two biotech startups, and partnering with drugmakers such as Novo and Bristol Myers Squibb. While CEO Dario Amodei has made bold predictions about biological progress and curing cancer, medical professionals and industry experts warn that most drugs fail in clinical trials.